Introduction | |
![]() |
|
Criteria for the Choice of Antimicrobial Agent: Examining the Balance Between Efficacy, Safety, and Tolerability | |
![]() |
Professor Andy Hoepelman Head of Department of Acute Medicine and Infectious Diseases Professor of Department of Medicine University Medical Center Utrecht Utrecht, The Netherlands |
![]() |
|
Clinical Pharmacokinetic/Pharmacodynamic Evidence Regarding the Safety of Levofloxacin | |
![]() |
Professor William Craig Professor of Department of Medicine University of Wisconsin Madison, WI, USA |
![]() |
|
Comparison of Safety Profile of Levofloxacin and Other Agents ( ![]() ![]() |
|
![]() |
Professor Javier Garau Head of Department of Medicine Hospital Mutua de Terrassa Associate Professor of Medicine University of Barcelona Barcelona, Spain |
![]() |
|
Drug-Drug Interactions with Levofloxacin: Tolerance and Contraindications | |
![]() |
Professor Enrico Mini Associate Professor of Chemotherapy Department of Preclinical and Clinical Pharmacology University of Florence Florence, Italy |
![]() |
|
Levofloxacin Safety Update Focusing on Cardiotoxicity | |
![]() |
Professor Ethan Rubinstein Professor of Department of Internal Medicine and Unit of Infectious Diseases Tel Aviv University School of Medicine, Tel Aviv, Israel |
![]() |
|
Summary |